ABILIFY ASIMTUFII
OTSUKA PHARMACEUTICAL CO LTD
Quick answers
Is there a shortage of ABILIFY ASIMTUFII in Canada?
No. There is no current shortage of ABILIFY ASIMTUFII 960MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ABILIFY MAINTENA
OTSUKA PHARMACEUTICAL CO LTD
AG-ARIPIPRAZOLE
ANGITA PHARMA INC.
NRA-ARIPIPRAZOLE
NORA PHARMA INC
APO-ARIPIPRAZOLE
APOTEX INC
SANDOZ ARIPIPRAZOLE
SANDOZ CANADA INCORPORATED
AURO-ARIPIPRAZOLE
AURO PHARMA INC
DIN
02554577
Strength
960MG
Dosage Form
Suspension (Extended-Release)
Route
Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from OTSUKA PHARMACEUTICAL CO LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
15MG · DIN 02322404
2MG · DIN 02322374
30MG · DIN 02322455
20MG · DIN 02322412
10MG · DIN 02322390
5MG · DIN 02322382
720MG · DIN 02554569
400MG · DIN 02420872
300MG · DIN 02420864
60MG · DIN 02240602
DIN 02437511
DIN 02437538